References
- Ach K, Khochtali I, Ajmi ST, Beizig AM, Chadli MC, Ajina MZ, et al. (2005). Factitious Cushing’s syndrome: two case reports. Rev Med Intern 26;973–976.
- Afshari R, Majdzadeh R, Balali-Mood M. (2004). Pattern of acute poisonings in Mashhad, Iran 1993–2000. J Toxicol Clin Toxicol 42:965–975.
- Afshari R, Shafaeeyan H, Afshari R. (2006a). An epidemiologic study of opioid-dependent subjects who were volunteered for opioid detoxification in Iran, 2005. Clin Toxicol (Phila) [Abstract] 44:581–582.
- Afshari R, Afshari R. (2006b). New illicit opioid dependence, a suspected combination of opioids and steroids. Proceedings of the 26th European Association of Poisons Centres and Clinical Toxicologists (EAPCCT), Prague, Czech Republic: 177–178.
- Ahmadi J, Maharlooy N, Alishahi M. (2004). Substance abuse: prevalence in a sample of nursing students. J Clin Nurs 13:60–64.
- Beauregard C, Dickstein G, Lacroix A. (2002). Classic and recent etiologies of Cushing’s syndrome: diagnosis and therapy. Treat Endocrinol 1:79–94.
- Dollery C. (1999). Dollery’s Therapeutic Drugs. CD-ROM DATABASE Release, 1.0. Harcourt Brace, London. [Ref Type: Electronic Citation]
- Friedman TC. (2006). An update on the overnight dexamethasone suppression test for the diagnosis of Cushing’s syndrome: limitations in patients with mild and/or episodic hypercortisolism. Exp Clin Endocrinol Diab 114:356–360.
- Gutstein HB, Akil H. (2001). Opioid analgesics. In: Hardman JG, Limbird LE, Goodman Gilman A (Eds.), Goodman & Gilman’s The pharmacological Basis of herapeutics (569). McGraw-Hill, New York.
- Hopkins RL, Leinung MC. (2005). Exogenous Cushing’s syndrome and glucocorticoid withdrawal. Endocrinol Metab Clin North Am 34:371–384.
- Katabami T, Obi R, Shirai N, Naito S, Saito N. (2005). Discrepancies in results of low- and high-dose dexamethasone suppression tests for diagnosing preclinical Cushing’s syndrome. Endocr J 52:463–469.
- Kaufman J. (1984). Diseases of the adrenal cortex of dogs and cats. Mod Vet Pract 65:513–516.
- Nieman LK. (2002). Diagnostic tests for Cushing’s syndrome. Ann N Y Acad Sci 970: 112–118.
- Odagiri E, Naruse M, Terasaki K, Yamaguchi N, Jibiki K, Takagi S, et al. (2004). The diagnostic standard of preclinical Cushing’s syndrome: evaluation of the dexamethasone suppression test using various cortisol kits. Endocr J 51:295–302.
- O’Hare JP, Vale JA, Wood S, Corrall RJ. (2005). Factitious Cushing’s syndrome. Acta Endocrinol 111:165–167.
- Samaras K, Pett S, Gowers A, McMurchie M, Cooper DA. (2005). Iatrogenic Cushing’s syndrome with osteoporosis and secondary adrenal failure in human immunodeficiency virus-infected patients receiving inhaled corticosteroids and ritonavir-boosted protease inhibitors: six cases. J Clin Endocrinol Metab 90:4394–4398.
- Tavana-Elmi F. (2006). Norgesic illicit administration for abstinence. Khorasan 16338, 9. January 28, 2006. Mashhad, Iran. [Ref Type: Newspaper]
- Vasirian H. (2006). Health alert in relation to new illicit drugs. Khabar-e-Janub 7115, 31. January 28, 2006. Shiraz, Iran. [Ref Type: Newspaper]
- Verret JL, Gaborieau F, Chabasse D, Rohmer V, Avenel M, Smulevici A. (1982). Cutaneous alternariosis revealing Cushing’s disease. A case with ultrastructural study, Ann.Dermatol.Venereol 109:841–846.
- Villanueva RB, Brett E, Gabrilove JL. (2000). A cluster of cases of factitious Cushing’s syndrome. Endocr Pract 6:143–147.
- Williams GH, Dluhy RG. (2005). Disorders of the adrenal cortex. In: Kasper DL, Braunwald E, Fauci AS, Hauser SL, Longo DL, Jameson JL, ( Eds.), Harrison’s Principles of Internal Medicine (p 2127). Mc Graw-Hill, New York.
- Wisniewski AB, Brown TT, John M, Cofranceso, J, Jr, Golub, ET, Ricketts EP, et al. (2006). Cortisol levels and depression in men and women using heroin and cocaine. Psychoneuroendocrinology 31:250–255.
- Yanovski JA, Cutler GB, Jr. (1994). Glucocorticoid action and the clinical features of Cushing’s syndrome. Endocrinol Metab Clin North Am 23:487–509.